Canada · Delayed Price · Currency is CAD PharmaTher Holdings Statistics
Total Valuation
CSE:PHRM has a market cap or net worth of CAD 10.01 million. The enterprise value is 8.89 million.
| Market Cap | 10.01M |
| Enterprise Value | 8.89M |
Important Dates
The next estimated earnings date is Friday, October 31, 2025.
| Earnings Date | Oct 31, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CSE:PHRM has 91.02 million shares outstanding. The number of shares has increased by 0.33% in one year.
| Current Share Class | 91.02M |
| Shares Outstanding | 91.02M |
| Shares Change (YoY) | +0.33% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 19.54% |
| Owned by Institutions (%) | 0.05% |
| Float | 73.11M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 10.28 |
| P/TBV Ratio | 10.28 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.82 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.11
| Current Ratio | 3.11 |
| Quick Ratio | 3.11 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -92.20% and return on invested capital (ROIC) is -57.53%.
| Return on Equity (ROE) | -92.20% |
| Return on Assets (ROA) | -48.47% |
| Return on Invested Capital (ROIC) | -57.53% |
| Return on Capital Employed (ROCE) | -156.50% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -47.62% in the last 52 weeks. The beta is 3.18, so CSE:PHRM's price volatility has been higher than the market average.
| Beta (5Y) | 3.18 |
| 52-Week Price Change | -47.62% |
| 50-Day Moving Average | 0.28 |
| 200-Day Moving Average | 0.28 |
| Relative Strength Index (RSI) | 24.38 |
| Average Volume (20 Days) | 444,122 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -1.52M |
| Pretax Income | -1.53M |
| Net Income | -1.53M |
| EBITDA | -1.52M |
| EBIT | -1.52M |
| Earnings Per Share (EPS) | -0.02 |
Balance Sheet
The company has 1.12 million in cash and n/a in debt, giving a net cash position of 1.12 million or 0.01 per share.
| Cash & Cash Equivalents | 1.12M |
| Total Debt | n/a |
| Net Cash | 1.12M |
| Net Cash Per Share | 0.01 |
| Equity (Book Value) | 973,544 |
| Book Value Per Share | 0.01 |
| Working Capital | 772,812 |
Cash Flow
| Operating Cash Flow | -1.21M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CSE:PHRM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.33% |
| Shareholder Yield | -0.33% |
| Earnings Yield | -15.24% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |